Compounds > arginine

arginine and Antithrombin III Deficiency

arginine has been researched along with Antithrombin III Deficiency in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (20.00)	18.7374
1990's	8 (53.33)	18.2507
2000's	4 (26.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agishi, T; Akizawa, T; Hirasawa, Y; Matsui, N; Ota, K	1
Eto, T; Gondo, H; Hamasaki, N; Ichimiya, H; Kato, K; Kawamoto, M; Kayamori, Y; Muta, T; Okamura, T; Shibuya, T; Urata, M; Wada, Y; Yamanaka, M	1
Brüggener, E; Hauptmann, J; Müller, H	1
Mihara, H; Satsuma, J; Yoshihara, H	1
De Waele, M; Jochmans, K; Liebaers, I; Lissens, W; Peeters, S; Vervoort, R	1
Fujiwara, T; Niiya, K; Ozawa, T; Sakuragawa, N; Sato, S; Suzuki, K; Takikawa, Y	1
Kario, K; Koide, M; Matsuo, T	1
Kikumoto, R; Tamao, Y	1
Furukawa, K; Hirahara, K; Koga, S; Narita, Y; Ohteki, H	1
Gordan, L; Gorman, R; Kitchens, C; Zumberg, M	1
Itakura, M; Iwahana, H; Saito, S; Shigekiyo, T; Tomonari, A; Yoshimoto, K	1
Kario, K; Kodama, K; Matsuo, T; Okamoto, S	1
Matsuo, M; Matsuo, T; Sakai, R; Yamada, T	1
Hashimoto-Gotoh, T; Nakagawa, M; Takada, O; Tanaka, S; Tsuji, H; Uno, M; Wagatsuma, M	1
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M	1

Reviews

3 review(s) available for arginine and Antithrombin III Deficiency

Article	Year
Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation. Artificial organs, 1997, Volume: 21, Issue:9 Topics: Anticoagulants; Antithrombin III Deficiency; Antithrombins; Arginine; Contraindications; Extracorporeal Circulation; Granulocytes; Heparin; Humans; Leukocyte Elastase; Pipecolic Acids; Sulfonamides; Thrombocytopenia	1997
Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis. Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:6 Topics: Acute Disease; Animals; Anticoagulants; Antithrombin III Deficiency; Antithrombins; Arginine; Disease Models, Animal; Extracorporeal Circulation; Intracranial Embolism and Thrombosis; Pipecolic Acids; Rats; Sulfonamides	1997
Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805). Seminars in thrombosis and hemostasis, 1992, Volume: 18, Issue:2 Topics: Antibodies; Antithrombin III Deficiency; Antithrombins; Arginine; Blood Platelets; Heparin; Heparin Antagonists; Humans; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombocytopenia	1992

Other Studies

12 other study(ies) available for arginine and Antithrombin III Deficiency

Article	Year
Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8 Topics: Aged; Anticoagulants; Antithrombin III Deficiency; Arginine; Female; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Renal Dialysis; Retrospective Studies; Sulfonamides	2003
Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. European journal of haematology, 2005, Volume: 75, Issue:2 Topics: Adult; Antithrombin III Deficiency; Arginine; DNA Mutational Analysis; Female; Frameshift Mutation; Heterozygote; Humans; Mesenteric Vascular Occlusion; Mesenteric Veins; Pipecolic Acids; Salvage Therapy; Sulfonamides; Treatment Outcome; Venous Thrombosis	2005
[Substitution of antithrombin III by synthetic thrombin inhibitors]. Folia haematologica (Leipzig, Germany : 1928), 1984, Volume: 111, Issue:4 Topics: Animals; Antithrombin III; Antithrombin III Deficiency; Arginine; Carbon Tetrachloride Poisoning; Fibrinogen; Heparin; Phenylpyruvic Acids; Pipecolic Acids; Platelet Count; Rats; Sulfonamides; Thrombin; Thrombosis	1984
[Mathematical simulation of the blood coagulation system]. Nihon seirigaku zasshi. Journal of the Physiological Society of Japan, 1984, Volume: 46, Issue:4 Topics: Adult; Anticoagulants; Antithrombin III; Antithrombin III Deficiency; Arginine; Blood Coagulation; Factor VII; Factor VIIa; Hemophilia A; Heparin; Humans; Male; Mathematics; Microcomputers; Models, Biological; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin; Prothrombin Time; Sulfonamides	1984
Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood, 1994, Jan-01, Volume: 83, Issue:1 Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Arginine; Base Sequence; DNA; Female; Glycine; Humans; Infant, Newborn; Molecular Sequence Data; Pedigree; Point Mutation; Polymerase Chain Reaction; Thrombosis	1994
Antithrombin Morioka (Cys 95-Arg): a novel missense mutation causing type I antithrombin deficiency. Thrombosis and haemostasis, 1997, Volume: 77, Issue:2 Topics: Adult; Antithrombin III Deficiency; Antithrombin Proteins; Antithrombins; Arginine; Codon; Cysteine; DNA Mutational Analysis; Humans; Male; Point Mutation; Protein Conformation	1997
The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. The Journal of thoracic and cardiovascular surgery, 2001, Volume: 122, Issue:6 Topics: Adult; Anticoagulants; Antithrombin III Deficiency; Aortic Valve; Arginine; Cardiopulmonary Bypass; Heart Valve Prosthesis Implantation; Humans; Male; Pipecolic Acids; Sulfonamides	2001
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure. Thrombosis and haemostasis, 2001, Volume: 86, Issue:6 Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin	2001
Two new nonsense mutations in type Ia antithrombin III deficiency at Leu 140 and Arg 197. Thrombosis and haemostasis, 1992, Oct-05, Volume: 68, Issue:4 Topics: Antithrombin III; Antithrombin III Deficiency; Arginine; Base Sequence; Genes, Dominant; Immunoelectrophoresis; Leucine; Molecular Sequence Data; Mutation; Pedigree; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length	1992
Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis. Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1991, Volume: 19, Issue:1 Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Antithrombins; Arginine; Heparin; Humans; Kidney Failure, Chronic; Male; Peptide Hydrolases; Pipecolic Acids; Renal Dialysis; Sulfonamides	1991
Congenital antithrombin III deficiency (AT-III Kyoto): identification of a point mutation altering arginine-406 to methionine behind the reactive site. Thrombosis research, 1991, Oct-01, Volume: 64, Issue:1 Topics: Adult; Amino Acid Sequence; Antithrombin III; Antithrombin III Deficiency; Arginine; Base Sequence; Binding Sites; Gene Amplification; Humans; Isoelectric Focusing; Male; Methionine; Molecular Sequence Data; Mutation; Oligonucleotides; Sequence Homology, Nucleic Acid	1991
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models]. Rinsho byori. The Japanese journal of clinical pathology, 1987, Volume: Spec No 73 Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior	1987